Aureka Biotechnologies announced the completion of a US$100 million Series B financing round on August 10, 2026. Granite Asia provided the first tranche as the sole investor, while a leading …
A growing school of thought within artificial intelligence suggests that the long-term competitive advantage in AI may no longer reside primarily in the models themselves. As advanced AI systems increasingly …
At the 17th Annual Meeting of the New Champions (Summer Davos 2026), organized by the World Economic Forum in Dalian on June 23, Gong Yingying, Founder and Chairwoman of Yidu …
Marking more than 15 years of partnership with Europe’s drug discovery community, Viva Biotech is reinforcing its dedication to the region through operational consistency, steady growth, and scalable collaboration. As …
